东阿阿胶 (000423)

1. Key Indicators

• Total Shares(W): 64397.68
• Circulating A-Shares(W): 64301.81
• Earnings Per Share(RMB): 1.9781
• Net Assets Per Share(RMB): 15.4476
• Operating Revenue(W RMB): 476637.06
• Total Profit(W RMB): 150297.21
• Net Profit Attributable to Parent(W RMB): 127382.01
• Net Profit Growth Rate(%): 10.58
• Weighted Return on Equity(%): 12.1400
• Operating Cash Flow Per Share(RMB): 2.0340
• Undistributed Profit Per Share(RMB): 13.2831
• Capital Reserve Per Share(RMB): 0.6022

---

2. Main Business

The main business covers:

• Research, development, production, and sales of donkey-hide gelatin and related series products, as well as other Chinese patent medicines.
• Industrial investment and equity investment.
• Livestock breeding, acquisition, slaughtering, processing, and sales.
• Planting, production, acquisition, processing, and sales of Chinese medicinal herbs.
• Production, processing, and sales of health foods and general foods.
• Production and sales of cosmetics (skin care products), health equipment, medical devices, small kitchenware, cleaning supplies, and household appliances.
• Health consulting and services, tourism services, conference exhibition and reception services, and handicraft sales.

---

3. Company Basic Information

• Company Name: Dong-E-E-Jiao Co., Ltd.
• Listing Date: 1996-07-29
• Industry: Pharmaceutical Manufacturing
• Address: No. 78 Ejiao Street, Dong'e County, Shandong Province, China
• Website: www.dongeejiao.com
• Company Profile: The company was established in February 1993 through the restructuring of the original Dong'e Ejiao Factory. Initially, its productive net assets were converted into 16.8 million state-owned shares, and 25 million employee shares were privately placed. After the initial public offering in July 1996, the total number of shares at the time of listing was 62.38 million. The 6.6 million internal employee shares, which occupied the quota, were listed and traded together with the public shares on July 29, 1996.

---

4. Top 10 Circulating Shareholders

Rank	Institution Name	Institution Type	Shares Held (W)	Percentage Held (%)
1	China Resources Dong'e Ejiao Co., Ltd.	General Legal Person	15135.17	23.54
2	China Resources Pharmaceutical Investment Co., Ltd.	General Legal Person	6564.46	10.21
3	Hong Kong Securities Clearing Company Ltd.	Northbound Capital	4152.30	6.46
4	CSI 500 Exchange Traded Open-End Index Securities Investment Fund	Fund	657.84	1.02
5	Beijing Chengyang Investment Co., Ltd. - Chengyang No.1 Private Securities Investment Fund	Private Securities Investment Fund	393.95	0.61
6	Bocom Schroders New Growth Hybrid Securities Investment Fund	Fund	340.71	0.53
7	UBS Asset Management (Singapore) Ltd. - UBS (Lux) Investment SICAV	QFII	328.64	0.51
8	China International Capital Corporation Limited	Broker	312.64	0.49
9	ChinaAMC CSI Traditional Chinese Medicine ETF	Fund	281.32	0.44
10	Harvest Taihe Hybrid Securities Investment Fund	Fund	212.85	0.33

---

5. Concept Sectors

• Rural Revitalization
• Prepared Dishes
• Tourism Concept
• Margin Trading & Securities Lending
• High-Performance Stock
• QFII Heavy Holdings
• Broker Heavy Holdings
• High Dividend Yield Stock
• Share Repurchase Plan
• QFII New Entry
• Northbound Heavy Holdings
• Mainland-Hong Kong Stock Connect Heavy
• Non-Cyclical Stock
• High Dividend Payout Stock
• Private Placement New Entry
• SZSE Value
• SZSE Component Index
• Mid-Cap Growth
• SZSE 300
• SZSE Dividend
• CNI Growth
• SZSE Growth
• CCTV 50
• CSI Central SOEs
• Investment Clock
• Analyst Index

---

Remarks

• Data update date: 2026-01-01
• Data source: Public Market Information